title: When Not All That Counts Can Be Counted: Economic Evaluations And The Value Of Vaccination.
abstract: With vaccination efforts forced to compete for scarce resources at a time when national health budgets, global health resources, and the global donor community are facing considerable strains, advocates of vaccines have sought to better identify, measure, and articulate the value of vaccination. Critics of current analyses of the value of vaccination argue that a broader view is required, one that includes the additional economic benefits of vaccines or acknowledges the social and ethical aims advanced by vaccination programs. Much of this work has paid inadequate attention to the need to apply any expanded view of value consistently across medical interventions, to the close and complex integration of vaccination efforts with other health initiatives, and to the fact that subjectivity and judgments are present in quantitative and qualitative evidence alike. To fully realize the value of vaccination, far more attention, investment, and research are required to better understand the deliberations and decision-making processes by which any kind of evidence is translated into policy.
authors: Jason L. Schwartz (jason.l.schwartz@yale.edu) is an assistant professor in the Department of Health Policy and Management, Yale School of Public Health, in New Haven, Connecticut.
authors: Jason L
authors: JL
authors: Schwartz
authors: Adel Mahmoud is a professor in the Woodrow Wilson School of Public and International Affairs and the Department of Molecular Biology, both at Princeton University, in New Jersey.
authors: Adel
authors: A
authors: Mahmoud
mesh_terms: D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006801:Humans; D017589:Immunization Programs / Q000191:economics*; D014611:Vaccination / Q000191:economics*
keywords: Decision-Making; Evidence; Public Health; Vaccination